In this regard, intranasal Tri:ChAd:TB immunization in BCG-primed hosts strongly boosted CD4+ T-cell responses to TB10.4 and RpfB (Fig. 2E), which could have contributed to the markedly enhanced protection. The gene discussed is CD4; the disease is tuberculosis.